These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9987197)

  • 1. The use of some hydrophobic substances in tablet technology.
    Vitková M; Chalabala M
    Acta Pharm Hung; 1998 Nov; 68(6):336-44. PubMed ID: 9987197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T; Ohta T; Taira T; Ogawa Y; Sakai Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Mar; 370(1-2):1-7. PubMed ID: 19059327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulations.
    Roberts M; Ford JL; MacLeod GS; Fell JT; Smith GW; Rowe PH; Dyas AM
    J Pharm Pharmacol; 2004 Mar; 56(3):299-305. PubMed ID: 15025854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants.
    Uğurlu T; Turkoğlu M
    Int J Pharm; 2008 Apr; 353(1-2):45-51. PubMed ID: 18160235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lubrication in tablet formulations.
    Wang J; Wen H; Desai D
    Eur J Pharm Biopharm; 2010 May; 75(1):1-15. PubMed ID: 20096779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of shear intensity and total shear on properties of blends and tablets of lactose and cellulose lubricated with magnesium stearate.
    Mehrotra A; Llusa M; Faqih A; Levin M; Muzzio FJ
    Int J Pharm; 2007 May; 336(2):284-91. PubMed ID: 17236729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate.
    Dürig T; Venkatesh GM; Fassihi R
    J Pharm Pharmacol; 1999 Oct; 51(10):1085-92. PubMed ID: 10579678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of the properties of tablets made from directly compressible starch and its mixtures with directly compressible lactose].
    Muzíková J; Moucková E
    Ceska Slov Farm; 2006 Sep; 55(5):236-41. PubMed ID: 17128594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycerin fatty acid esters as a new lubricant of tablets.
    Aoshima H; Miyagisnima A; Nozawa Y; Sadzuka Y; Sonobe T
    Int J Pharm; 2005 Apr; 293(1-2):25-34. PubMed ID: 15778041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dry binders, Vivapur 102, Vivapur 12 and the effect of magnesium stearate on the strength of tablets containing these substances].
    Muzíková J; Horácek J
    Ceska Slov Farm; 2003 Jul; 52(4):176-80. PubMed ID: 12924068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compaction properties of isomalt.
    Bolhuis GK; Engelhart JJ; Eissens AC
    Eur J Pharm Biopharm; 2009 Aug; 72(3):621-5. PubMed ID: 19327398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.